Anna Conway

UNSW Sydney

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Phillip Keen

AUSTRALIA

View details

Mark Montebello

University of Sydney

AUSTRALIA

View details

Guillaume Fontaine

Assistant Professor

McGill University

CANADA

View details

Louise Causer

Senior Lecturer

UNSW Sydney

AUSTRALIA

View details

Beth Catlett

Macquarie University

AUSTRALIA

View details

Janaki Amin

Macquarie University

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anna Conway

Research Interests

Explore related searches

Contact this professor

Articles (10)

Special Issue and Sixth Contemporary Drug Problems Conference—Embracing Trouble: New Ways of Doing, Being and Knowing

Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs

Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs

Health-related quality of life of people who inject drugs

Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot

A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage Study

Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis

Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study

Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study

People engaged in opioid agonist treatment as a counterpublic during the COVID-19 pandemic in Australia: A qualitative study

Collaborators (6)

Phillip Keen

Mark Montebello

Guillaume Fontaine

Louise Causer

Beth Catlett

Janaki Amin

Make your next move.